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The aim of this study was to compare the long-term consequences of refractory epileptic seizures for intellectual functioning in
pediatric and adult patients, taking the severity of the epilepsy into consideration. Thirty-four patients, 17 children (mean age
10.2 years) and 17 adults (mean age 24.4 years) were tested twice with the age-appropriate version of Wechsler’s Intelligence
Scales. The mean test–retest interval in the two groups was 3.5 and 6.0 years, respectively. There were no statistically significant
differences between the groups with respect to severity of the epilepsy at Test 1, as indicated by retrospective assessments of
seizure severity, interictal EEG pathology, and number of antiepileptic drugs received per patient. Assessments of changes in
these variables during the test–retest interval did not indicate different courses of the disease in the two groups. Despite these
similarities, a statistically significant difference was found between the children and the adults regarding changes in intellectual
functioning. In the children, there was a decline in mean intelligence quotient (IQ) scores during the test–retest interval, while
the IQ scores increased in the adult group. It is concluded that recurrent seizures may represent a considerable risk for intellectual
decline in children, while intellectual functioning seem to be less vulnerable in adults with early onset of epilepsy.
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INTRODUCTION
The effects chronic epilepsy may have on intellectual
functioning are of great concern to many patients and
their relatives. They are afraid that the illness may lead
to a gradual deterioration. However, longitudinal stud-
ies of patients who respond to drug treatment, have
failed to demonstrate any intellectual decline. This ap-
plies both to children1, 2 and adults3–5. About 20%
of patients with epilepsy, however, do not respond to
drug therapy6. Intractability may be due to underly-
ing pathological processes that are more severe than,
or different from, those in patients with a good re-
sponse7, 8. Yet, adult patients with intractable seizures
may not experience intellectual decline4, 9, 10, while
children with poor seizure control seem to be at risk
of intellectual retardation11–13. Thus, it seems that the
long-term effects of intractable seizures in children are
more serious than in adults. The evidence presented is
not conclusive, however, since descriptions of seizure
types and seizure frequencies are not given in com-
parable units. Hence, it is not possible to conclude
from these studies whether the children may have had
a more severe seizure disorder than the adults. It would
be preferable to have some common measures of the
severity of the seizure condition, and, in follow-up
studies, of the changes in the condition.
The present study, therefore, was undertaken to
explore and compare the consequences of recurrent
seizures for intellectual functioning in children and
adults, taking both seizure severity and course of the
disorder into consideration.
MATERIALS AND METHODS
Patient selection
Patients were recruited among 162 consecutive
patients included in the epilepsy surgery program at
the National Center for Epilepsy, Norway, during the
previous 10 years14. Those who had had an IQ testing
during earlier referrals to the center were considered
for the study. At the time of the first testing (Test 1),
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the patients were referred to the epilepsy center for an
expert evaluation and treatment of their seizures. They
were subsequently treated with antiepileptic drugs for
an average of 5 years before they were recognized
as surgical candidates. The second testing (Test 2)
was administered as part of the pre-operative eval-
uation. Patients were included in the study if they
had complete protocols of the Norwegian versions of
the Wechsler Intelligence Scale for Children Revised
(WISC-R)15 or the Wechsler Adult Intelligence Scale
(WAIS)16, and were at least 18 years of age at Test 1,
or less than 18 years of age at Test 2. Seventeen chil-
dren (6–17 years of age at Test 2) and 17 adults (18–35
years of age at Test 1) fulfilled the criteria.
The selected patients may have had a more severe
seizure condition than the majority of our surgical
candidates. However, this would pertain to both the
pediatric and the adult patients and thus not violate the
basis for the comparisons between the two groups.
One child and one adult patient were considered
for corpus callosotomy, while resective surgery was
planned in the remainder.
In addition to these 34 patients, complete test proto-
cols were available in 15 patients who were pediatric
patients at Test 1 but adults at Test 2. Because it was
not possible to decide whether changes in IQ scores
in these patients had taken place during childhood or
later, their data were not included in the statistical
comparisons between children and adults, but were
evaluated separately to give some additional informa-
tion on long-term consequences of recurrent seizures.
Demographic data from this additional group are pre-
sented in the last column of Table 1, under the heading
‘Children retested as adults’.
Methodological issues pertaining to the
intelligence tests
The psychometric properties of the Norwegian stan-
dardization of WISC-R and WAIS, as described in the
handbooks, fulfil standard criteria15, 16.
Practice effects
Upon retesting with intelligence tests under stable
conditions, with test–retest intervals between 2 and
20 weeks, the results obtained in normal persons
will usually improve by an average of 5–7 points in
Full Scale IQ scores. Such practice effects are ob-
served to the same extent in normal children and
normal adults17–19. However, studies of patients with
uncontrolled seizures fail to find appreciable test–
retest improvements3, 4, 20, 21. Consequently, the prac-
tice effects might be negligible in the present study
of patients with frequent seizures, who were retested
after relatively long intervals. Besides, the test–retest
intervals did not differ between the groups. Practice
effects, therefore, were not expected to cause any sys-
tematic differences between the groups.
IQ scores
Verbal, Performance and Full Scale IQ (FSIQ) scores
were computed for each patient using Norwegian
norm tables15, 16, 22. IQ scores are age adjusted in both
children and adults. Difference scores (Test 2–Test 1)
were computed based on the individual Verbal, Perfor-
mance and FSIQ scores.
Seizure-related factors that may influence the
test performance
Test performance may be influenced by factors such
as seizure activity3, 23–27, pathological brain activity
as seen on the EEG28–31, and side effects of the
antiepileptic drugs (AEDs)32–34. Systematic differ-
ences between the groups with respect to these factors
could contribute to differences in the test results. Con-
sequently, attempts were made to estimate these fac-
tors retrospectively in the medical files of each patient
as described in the following.
Seizure severity
Number of seizures during the previous month prior to
the two test occasions were recorded, based either on
the patients’ own seizure diaries or on the daily records
kept by the staff. Many patients had several seizure
types, and in some patients the seizure types changed
over time. Therefore, a mere count of seizures would
not give an adequate evaluation of the seizure sever-
ity. The need for expressing the seizure severity rather
than the seizure frequency is underlined by several au-
thors, and appropriate scales are available35–37. How-
ever, these scales cannot be used retrospectively. Thus,
in the present study, clinically based assessments of
seizure severity were performed. Three experienced
epileptologists rated the records of each patient inde-
pendently and blindly, taking both seizure frequency
and seizure types into consideration. The seizure con-
dition before Test 1 was rated along a graded 5-point
scale ranging from 0 ‘no seizures’ to 4 ‘severe seizure
condition’. The ratings were highly reliable (Kendall
coefficient of concordance = 0.90, P< 0.001). In-
dividual changes in the seizure condition between
test sessions were rated along a graded 7-point scale
ranging from −3 ‘much worse’ to +3 ‘much bet-
ter’ (Kendall coefficient of concordance = 0.94, P<
0.001). Examples of ratings are given in Table 2.
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Table 1: Demographics and seizure-related variables.
Variable Study groups Children retested
Children Adults P-value as adults
1. Number of patients 17 17 15
2. Sex (F/M) 8/9 7/10 NSa 10/5
3. Etiology, number of patients
Idiopathic or crypt./symptomatic 14/3 13/4 NSd 9/6
Cerebrovascular lesion 1 0 0
Intracranial infection 1 2 1
Perinatal encephalopathy 0 1 1
Asphyxia 1 1 0
Post-traumatic 0 0 2
Tumour 0 0 2
4. Age at seizure onset, mean yr (SD) 5.0 (3.0) 9.5 (7.2) <0.05b 5.3 (3.5)
5. Age at Test 1, mean (SD) 10.2 (2.6) 24.4 (4.6) 13.6 (2.6)
6. Seizure severity at Test 1, median (q-range) 3.0 (2) 2.3 (1) NSc 1.3 (1)
7. EEG pathology prior to Test 1, median
(q-range)
2.0 (1) 2.0 (1) NSc 2.0 (2)
8. Number of AEDs received per patient at
Test 1, median (q-range)
1.0 (1) 2.0 (1) NSc 1.0 (2)
9. Duration of epilepsy at Test 1, mean yr (SD) 5.2 (2.9) 14.8 (9.0) <0.001b 8.3 (4.9)
10. Test–retest interval, mean yr (SD) 3.5 (2.5) 6.0 (4.8) NSb 11.0 (5.6)
11. Age at Test 2, mean (SD) 13.7 (2.6) 30.4 (6.0) 24.6 (5.1)
12. Change in seizure severity, median (q-range) 1.0 (6) 1.0 (5) NSc −4.0 (6)
13. Change in EEG pathology, median (q-range) −1.0 (2) 0.0 (1) NSc −1.0 (1)
14. Change in medication, median (q-range) 0.0 (1) 0.0 (1) NSc 0.0 (1)
15. Laterality of epileptogenic region, number of
patients
Left hemisphere/Right hemisphere 8/8 8/7 NSa 6/9
Generalized 1 1 0
16. Temporal/extratemporal location of
epileptogenic region, number of patients
11/5 15/1 NSd 10/5
17. Type of surgery planned, number of patients
Resection 16 16 15
Callosotomy 1 1 0
18. Seizure types previous month prior to Test 1,
number of patients
Atypical absences 0 0 NSa 2
Simple partial seizures 4 2 NSa 3
Complex partial seizures 12 13 NSa 12
Generalized tonic–clonic seizures
(sec. gen)
4 (3) 11 (10) <0.05a 6
Misc. (Tonic, atonic, myoclonic,
undetermined, etc.)
2 2 NSa 0
19. Seizure types previous month prior to Test 2,
number of patients
Atypical absences 1 0 NSa 0
Simple partial seizures 3 3 NSa 4
Complex partial seizures 14 14 NSa 14
Generalized tonic–clonic seizures
(sec. gen)
5 (4) 11 (10) <0.05a 9
Misc. (Tonic, atonic, myoclonic,
undetermined etc.)
2 2 NSa 1
Abbreviations: F, female; M, male; Crypt, cryptogenic; q-range, quartile range; Yr, years; SD, standard deviation; AEDs, antiepileptic drugs;
Sec. gen, secondarily generalized; Misc, miscellaneous. a Chi-squared; b Student’s t-test for independent samples; c Median test; d Fisher
exact probability test.
Interictal EEG pathology
For each patient, the interictal EEG records closest in
time to the test sessions were selected from the med-
ical files. In most patients, EEG records were taken a
few days or weeks ahead of the test sessions. In a few
patients, the records were done a couple of months
earlier. However, since the test occasions were sepa-
rated by several years in most patients, we assumed
that these samples of EEGs were, to some degree,
representative of the patients’ interictal EEG charac-
teristics at the time of the assessments. Summaries
of the EEG records were blindly evaluated by a se-
nior neurophysiologist with respect to degree (not lo-
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calization) of EEG pathology prior to Test 1, and
change in the degree of EEG pathology between Test 1
and Test 2. Both evaluations were made according
to graded 5-point scales, and comprised background
activity, focal slowing, persistent/paroxysmal activity,
sharp components, and spike and wave activity.
Number of AEDs
The use of AED monotherapy with drug serum lev-
els within the therapeutic range may have negligible
side effects on cognition, while combinations of drugs
are more likely to cause adverse effects33, 34. Thus,
the number of AEDs received per patient at the first
testing, and changes in these numbers from Test 1 to
Test 2, were recorded. Two children and one adult
were without medication at Test 1, none were without
medication at Test 2.
Data analysis
Categorical data in the two study groups were anal-
ysed using the chi-squared test wherever the require-
ments for this test were met. In 2 × 2 contingency
tables with few expected frequencies, the Fisher ex-
act probability test was performed. Ordinal-scale data
were compared using the median test. Comparisons
of continuous demographic variables were performed
by Student’s t-test for independent samples. The IQ
scores were submitted to analysis of variance. Post hoc
tests were performed using Duncan’s multiple range
test. To decide whether the changes from Test 1 to
Test 2 were influenced by regression toward the mean,
product-moment correlations were computed between
the IQ scores at Test 1 and the difference scores. Re-
gression toward the mean is significant if the initial
values are significantly inversely correlated with the
difference scores38. P-values less than 0.05 in two-
tailed tests were considered statistically significant.
All statistical analyses were run using ‘Statistica for
the Macintosh’39.
RESULTS
Demographic and seizure-related variables
Demographic and seizure-related variables of the two
study groups are presented in Table 1. All but two
patients in the present study had seizure onset in child-
hood, the children being on average 5 years old at
seizure debut, and the adults on average 9.5 years
old. This difference was statistically significant. There
were also significant differences between the groups
with respect to the duration of epilepsy at the ini-
tial testing, with a mean duration of 5.2 years in the
children and 14.8 years in the adults. More adults
than children had secondarily generalized tonic–clonic
seizures during the previous month prior to both test
occasions.
There were, however, no significant differences be-
tween the groups with respect to sex, etiological
syndromes or epilepsy syndromes. All patients but
one in each group had localization-related partial
epilepsy. One child had primarily generalized tonic–
clonic, atonic and atypical absence seizures of crypto-
genic etiology, while one adult had Lennox–Gastaut
syndrome of cryptogenic etiology and with tonic–
clonic and atonic seizures. Furthermore, there were no
between-group differences in laterality or location of
the epileptogenic region, nor in seizure severity, EEG
pathology and number of drugs per patient at Test 1.
Changes from Test 1 to Test 2 in the latter three vari-
ables did not differ between the groups (Table 1).
IQ scores
Mean Verbal, Performance, and FSIQ scores of the
two groups at the two test occasions are shown in Ta-
ble 3. Initially the children’s FSIQ scores were in the
lower end of the normal range (i.e. 85–115). At Test 2,
however, their scores had declined on average by 4.6,
6.1, and 5.9 points in Verbal, Performance, and FSIQ,
respectively. Mean FSIQ now fell below the normal
range. The adults had IQ scores well below the normal
range at Test 1, but in contrast to the changes in the
children, their corresponding scores increased by 4.2,
7.9, and 6.4 points. To assess whether these differences
between the two groups were significant, we subjected
the IQ scores to 2 (group)× 2 (test occasion) analyses
of variance (ANOVA).
There were no significant differences between the
groups with respect to mean IQ scores, both test oc-
casions taken together, nor were there any signifi-
cant test–retest changes, both groups taken together,
as shown by the insignificant main effects. How-
ever, significant interaction effects were revealed for
Group × Test occasion in all the three types of IQ
scores. This indicated that the decrease in IQ scores
seen in the pediatric patients and the increase in the
adults, represented significantly different courses. Post
hoc analyses showed that the changes in Performance
and FSIQ were statistically significant within each
group.
Post hoc between-group comparisons showed sig-
nificantly higher Verbal, Performance, and FSIQ
scores in the children at Test 1, but no significant dif-
ferences at Test 2.
Because the groups differed with respect to age at
onset of habitual seizures, we performed similar anal-
yses as shown in Table 2 with age at onset as a co-
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Table 2: Examples of seizure severity ratings.
Patients Ratings of sz-severity Ratings of change
Sz/month prior to Test 1 Rater Sz/month prior to Test 2 Rater
Abs SPS CPS GTC Misc A B C score Abs SPS CPS GTC Misc A B C score
HH 150 4 4 4 12 25 3 3 3 9
EA 25 2 3 2 2 7 100 15 16 −3 −3 −3 −9
HB 1 135 3 3 3 9 500 20 30 −1 0 0 −1
IT 1 9 1 2 1 4 6 −2 −1 −3 −6
Abbreviations: Sz, seizures; Abs, atypical absences; SPS, simple partial seizures; CPS, complex partial seizures; GTC, generalized
tonic–clonic seizures; Misc., miscellaneous seizure types: tonic, atonic, myoclonic, undetermined. Frequency of different seizure types prior to
Test 1 and Test 2 in four patients, and actual ratings by three epileptologists (rater A, B, and C) of seizure severity at Test 1 and change in
seizure severity from Test 1 to Test 2. The ratings of seizure severity were done using a graded 5-point scale ranging from 0, no seizures, to 4,
severe seizure condition. Ratings of change were done according to a graded 7-point scale ranging from −3, much worse, to 3, much better.
The individual patient’s score was the sum of the ratings. Thus, individual seizure severity ranged from 0 to 12, and individual change in
seizure severity from −9 to 9.
variate. The interaction effects were still significant in
Performance and FSIQ (F = 10.3, P< 0.01; F = 8.2,
P< 0.01, respectively), but not in Verbal IQ (F =
3.8, P> 0.06). No significant main effects were ob-
tained. Although the groups differed also in duration
of epilepsy at Test 1, this variable is dependent on the
age at onset of seizures and the age at Test 1, which
was part of the grouping criterion. Consequently, we
did not find it appropriate to use this variable as an
additional covariate.
The 15 children who were retested as adults (addi-
tional group) were on average 5.3 years of age at onset
of seizures (Table 1). They were on average 13.6 years
of age at Test 1 and 24.6 at Test 2. Mean Verbal, Per-
formance, and FSIQ scores at Test 1 were 83.8, 88.9,
and 84.7, respectively. These mean scores were not
significantly (NS) different from the corresponding
scores of the pediatric group at Test 1 (t-values were
0.5, NS; 0.5, NS; and 0.5, NS, respectively, t-test for
independent samples). During the test–retest interval,
which was on average 11 years, the additional group
declined in Verbal, Performance and FSIQ scores by
6.4, 7.7, and 7.7 points, respectively. The changes
were statistically significant (t-values were 3.2, P<
0.01; 2.4, P< 0.05; 3.2, P< 0.01, t-test for correlated
samples). The decline was not significantly different
from the decline in the pediatric group (t-values were
0.5, NS; 0.4, NS; and 0.5, NS; t-test for independent
samples).
DISCUSSION
In this retrospective study comparing changes in IQ
scores at two test occasions in pediatric and adult
patients with refractory seizures, we found signif-
icantly different courses in intellectual functioning
between the groups: The children’s scores declined,
while the adults’ increased. Post hoc analyses showed
that the within-group changes were significant in Per-
formance and FSIQ in both groups. These findings
are in agreement with previous longitudinal studies in
adults9, 10, and in children11–13. The differences be-
tween children and adults in the current study could
not be ascribed to differences in etiology or in epilepsy
syndromes. Furthermore, the results could probably
not be explained by a more severe epilepsy initially
in the children, or a more progressive course of their
disease, as indicated by assessments of seizure sever-
ity and other seizure-related variables (Table 1).
A bias might be introduced, however, if the patients
selected for the study initially were referred for neu-
ropsychological assessment in a period when they
temporarily had an increased seizure frequency. This
could give a test–retest gain in the adults and attenuate
the decline in the children. However, the changes in
seizure severity gave no indications that this was the
case (Z = 0.9, P> 0.3, sign test). Regression toward
the mean did not significantly influence the results in
either group.
We assume that the findings reflect a greater vul-
nerability of intellectual functioning in children than
in adults, due to different stages in the development
of intellectual abilities. This development may be con-
ceived as a cumulative process undergoing particularly
rapid growth in childhood40. Roughly, this growth can
be operationally defined by the increase in the sum
of WISC-R raw scores required from one year to the
next for a child to maintain mean scaled scores, i.e.
scaled scores of 10, and an average FSIQ15, as illus-
trated in Fig. 1. Rate of growth in intellectual abilities,
as defined here, decelerates and levels off in young
adulthood. This can be illustrated in the same way
by adding the raw scores necessary to maintain mean
scaled scores on the WAIS for successive age groups41
(see Fig. 1). Normal development, as reflected by the
curves in Fig. 1, depends on many factors. Among
these, maturational processes of the brain and optimal
opportunities for the child to learn from interaction
with a normal environment, are among the most essen-
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Fig. 1: Illustration of normal intellectual development (longer curve) and the slowing of development with gradually diminishing
FSIQ of case GA (shorter curve). In the WISC-R norm tables, which are based on the standardization samples of children at differ-
ent ages, the total number of correct solutions required to obtain a FSIQ of 100 increases by a certain amount from one age level
to the next. This amount operationally defines the normal intellectual development of children with average intelligence. By adding
the numbers of correct solutions (actually the raw scores) for each age level one can observe the normal growth in intellectual
abilities at successive ages (longer curve). Similar sums of raw scores from the WAIS show the intellectual development from age
16 to age 30. (To join the curves from the WISC-R and the WAIS into one smooth curve a parallel displacement had to be done
by adding a constant number to the WAIS values.) The actual number of correct solutions (raw scores) given by case GA, who
was tested four times with the WISC-R, are shown by the shorter curve, and the FSIQ scores she obtained are shown beneath
this curve. She was 9 years and 9 months of age at the first assessment, and was subsequently tested at the age of 11 years and
6 months, 13 years and 7 months, and 15 years and 2 months, respectively. GA had cryptogenic epilepsy with seizure onset at
1 year of age, and underwent right temporal lobe resection when she was 13 years of age. She has been completely seizure free
since then, i.e. for more than 15 years. Abbreviations: WISC-R, Wechsler Intelligence Scale for Children-Revised; WAIS, Wechsler
Adult Intelligence Scale; FSIQ: Full Scale Intelligence Quotient.
tial40, 42. Whether epilepsy interferes directly with the
maturational processes of the brain is a matter of con-
siderable debate43, 44. However, it is generally recog-
nized that an uncontrolled epilepsy may interfere with
the child’s cognitive functioning1, 12, 13, 45, 46 and with
its opportunity to interact with the environment47, 48.
This leads to disadvantages in scholastic as well as
social participation42, 49–52. Thus, the epileptic child’s
opportunities to learn from normal experience are dis-
turbed47, 48. This may interfere with the speed of intel-
lectual growth, and the child’s abilities may develop at
a slower rate and gradually lag behind those of its age-
mates. Because IQ scores are age adjusted, such slow-
ing is reflected by a diminishing IQ. This is illustrated
by the results after serial testing with the WISC-R of
the case GA in Fig. 1, showing a gradual decrease in
FSIQ scores despite a small gradual increase in raw
scores (see also the legend).
Similar explanations for the long-term conse-
quences for intellectual development in children with
early brain injuries have been proposed by Fletcher
et al.53 and Taylor and Alden54, and in patients with
epilepsy by Vargha-Khadem et al.55 and Glosser et
al.50 The latter authors related the delayed cognitive
development in their patients to the possible interfer-
ence of seizures with neural maturation during critical
periods in childhood. The present authors also assume
that disturbances of cognitive functioning and, in some
cases, a restricted life caused by frequent seizures,
may play a role in retarding intellectual development.
Neyens et al.56 argued that cognitive decline in chil-
dren with epilepsy seem to occur in close temporal
proximity to seizure onset, and may be caused by the
underlying pathophysiological processes. Our data are
not in unequivocal support of this hypothesis, as about
20% of the children who had had seizures for at least
5 years at Test 1 declined by 10 or more IQ points dur-
ing the test–retest interval.
The children had higher IQs than the adults at Test 1.
This might be a referral artefact, e.g. if the thresh-
old for being referred for neuropsychological assess-
ment was systematically different with respect to in-
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Table 3: Mean IQ scores and standard deviations in pediatric and adult patients.
Test 1 Test 2 Main effects Interactions
group test
F P F P F P
VIQ Children 86.8 (17.3) 82.2 (19.4) 0.1 NS 0.0 NS 5.3 <0.05a
Adult 80.1 (19.2) 84.2 (22.3)
PIQ Children 92.5 (15.8) 86.4 (15.8) 3.8 NS 0.3 NS 13.2 <0.001a
Adult 73.5 (20.7) 81.5 (20.7)
FSIQ Children 88.1 (16.6) 82.1 (18.6) 1.1 NS 0.0 NS 10.9 <0.01a
Adult 75.1 (20.5) 81.5 (22.3)
Abbreviations: VIQ, Verbal IQ; PIQ, Performance IQ; FSIQ, Full Scale IQ; NS, not significant.
a Two-way analysis of variance (ANOVA). Post hoc tests: Within-group changes Test1–Test 2: Children: VIQ, NS; PIQ, P< 0.05; FSIQ,
P< 0.05. Adults: VIQ, NS; PIQ, P< 0.01; FSIQ, P< 0.05. Between-group differences: Test 1: VIQ, P< 0.05; PIQ, P< 0.001; FSIQ,
P< 0.001. Test 2: VIQ, NS; PIQ, NS; FSIQ, NS.
tellectual functioning in children and adults. The dif-
ferences are, however, more likely due to the relatively
short seizure history at Test 1 in the children, namely
5.2 years on average. Children with a shorter seizure
history are reported to have higher IQs than children
with a longer duration of epilepsy45. The course of
the intellectual functioning in the pediatric patients
in the present study corroborates these findings. At
Test 2, the children had had seizures for an average
of 8.7 years, and their mean FSIQ had declined by
5.8 points and was no longer significantly different
from the FSIQ of the adult group. This is in agreement
with the ‘retarded growth’ hypothesis.
In accordance with a developmental model, we
would also expect an intellectual decline in the 15 chil-
dren who were retested as adults. However, although
the decline was statistically significant, the interpre-
tation of the results remains uncertain, because of a
significant regression toward the mean.
Intellectual decline in children with epilepsy seems
to depend on the severity of the epilepsy1, 2. In a 4-year
follow-up of children with epilepsy, Aldenkamp et
al.57 could find only insignificant drops in mean IQ
scores. The differences with the current findings may
be due to differences in the severity of the illness, as
22% became seizure free in the study by Aldenkamp et
al.57, while this was not the case in any of our patients.
One may wonder why the adults in the present
study, who had recurrent seizures of similar sever-
ity as the children, did not decline in IQ scores. It is
well known that seizures also disturb cognitive func-
tioning in adults3, 24, 25, 58, and interfere with their op-
portunities to participate in a normal way in intellec-
tual activities within education42, work59, 60, and so-
cial settings61, 62. In addition, the findings of atrophic
and sclerotic brain areas in adults with epilepsy raise
the question of whether long-standing seizures may
lead to progressive brain lesions63, 64 with concomi-
tant hazards for cognitive functioning65.
In spite of these potential hazards, however, we did
not find appreciable intellectual decline in any of the
17 adult patients, even after follow-up periods of more
than 15 years. Only three of them had minor decreases,
by 1–4 points, in FSIQ scores. In contrast, the adult
patients, as a group, experienced gains in Performance
and FSIQ. If practice effects may be disregarded, these
gains may be due to the introduction of AEDs with less
side effects. All but two adult patients had different
AEDs at Test 2 compared to Test 1. (Of the children,
13 had changes in types of drugs received, which may
have attenuated the decline to some degree.)
On the other hand, the adult patients had lower ini-
tial IQ scores than the children, and consequently less
room for further decline, as measured by the Wechsler
scales. They had a mean seizure history of 15 years at
Test 1, and, as all but two had seizure onset before the
age of 16, they might already have gone through a re-
tardation in their intellectual development. In addition,
more adults than children had generalized tonic–clonic
seizures prior to both test occasions, which may have
contributed to their lower level of performance. A
‘floor’-effect, therefore, may have limited the poten-
tial decline in some of the adults.
However, previous longitudinal studies in adult
patients with normal or low normal intelligence could
not find significant adverse changes in IQ scores4, 9, 10,
in agreement with the present findings. Two of these
studies9, 10 found small, but significant, gains in IQ
scores which may also have been effects of optimal-
ization of drug treatment.
The relative stability of functions in adult patients
with recurrent seizures is probably not limited to in-
telligence. Selva et al.9 found no significant decline
in measures of memory in a 2.4-year follow-up study.
Kalska4 reported no adverse changes in memory, cog-
nitive flexibility and motor function during a 10-year
test–retest interval. In the 10-year follow-up study by
Holmes et al.10, a slight but significant decline was
seen in six out of 16 neuropsychological tests, mostly
in measures of speed and visuo-spatial relations. How-
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ever, the percentage of results outside normal limits
was not changed after 10 years. The investigators con-
cluded that although no overall adverse changes were
seen in intellectual or neuropsychological functioning,
slight losses in selected areas could not be ruled out.
None of the above studies4, 9, 10 considered patients
with onset of epilepsy in adulthood. The long-term
cognitive effects of seizures in this group remain to
be decided. Mesial temporal sclerosis and slightly im-
paired memory seem to be present in adults with newly
diagnosed temporal lobe seizures, indicating that the
lesions may have preceded the seizures65. Recurrent
seizures may exacerbate the lesion66. The progres-
sive nature of epilepsy is, however, disputed43, 44, 65.
Holmes et al.10 regarded their findings as evi-
dence against a progressive process underlying drug-
resistant epilepsy in adults. On the other hand, a recent
cross-sectional study by Jokeit and Ebner67 indicated
that epileptic seizures may have a cumulative adverse
effect only discernible in adult intelligence after more
than 30 years with seizures.
An average decline in FSIQ of 5.9 points in chil-
dren in the current study may seem trifling. But 40%
of them declined by 10 or more points, while only one
child experienced a comparable gain. In the additional
group of children retested as adults, 47% declined by
10 or more points. We find this noteworthy.
Although the patients selected for this study may
not have been representative for the population of
our surgical candidates in all respects, with the addi-
tional group they constituted a substantial part (30%),
and represent those with an early onset of refractory
seizures, which may give the most serious long-term
consequences for intellectual functioning. This is a
group of surgical candidates most epilepsy centres will
encounter, unless they reject patients with low FSIQ
from their surgical program, as advocated by some
authors68, 69.
CONCLUSIONS
The present study corroborates the findings from pre-
vious studies4, 9–13: adult patients with an early onset
epilepsy may not experience a decline in IQ scores, de-
spite recurrent seizures over several years. The long-
term consequences of recurrent seizures in children
and adolescents may be more serious, as they seem
to be at risk for intellectual decline relative to age-
adjusted norms. According to our results, the differ-
ences are probably not due to a more severe or pro-
gressive seizure disorder in the pediatric patients.
As an explanation for the different trends seen in
children compared to adults, we proposed a devel-
opmental model, suggesting that intellectual abilities
may be particularly vulnerable to disturbances related
to recurrent seizures during the period of rapid de-
velopment in childhood. Consequently, drug treatment
that does not result in satisfactory seizure control in
children should not be unduly prolonged before surgi-
cal treatment is considered.
Only further investigations can decide whether the
present finding apply to patients with seizure onset in
adulthood.
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